J&J to seek U.S. authorization for booster
Johnson & Johnson plans to ask U.S. regulators to authorize a booster shot of its single-shot COVID-19 vaccine, according to a report by The New York Times. The Food and Drug Administration’s expert advisory committee is scheduled to meet on October 15.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook